L301(Neutrolis)

N/A

Report date: 2025/01/14 15:33:28
NME

Base Information

Drug NameL301(Neutrolis)
Drug Alias NameL301L-301L301(Neutrolis)L-301(Neutrolis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeutrolis Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeutrolis Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A